| Extracellular vesicles in multiple sclerosis: what are they telling us? M Sáenz-Cuesta, I Osorio-Querejeta, D Otaegui Frontiers in cellular neuroscience 8, 100, 2014 | 127 | 2014 |
| Methods for extracellular vesicles isolation in a hospital setting M Sáenz-Cuesta, A Arbelaiz, A Oregi, H Irizar, I Osorio-Querejeta, ... Frontiers in immunology 6, 50, 2015 | 125 | 2015 |
| Circulating microparticles reflect treatment effects and clinical status in multiple sclerosis M Sáenz-Cuesta, H Irizar, T Castillo-Triviño, M Muñoz-Culla, ... Biomarkers in medicine 8 (5), 653-661, 2014 | 90 | 2014 |
| HLA-DRB1* 15: 01 and multiple sclerosis: a female association? H Irizar, M Muñoz-Culla, O Zuriarrain, E Goyenechea, T Castillo-Triviño, ... Multiple Sclerosis Journal 18 (5), 569-577, 2012 | 79 | 2012 |
| Prognosis of Good syndrome: mortality and morbidity of thymoma associated immunodeficiency in perspective A Jansen, M van Deuren, J Miller, J Litzman, J de Gracia, ... Clinical Immunology 171, 12-17, 2016 | 78 | 2016 |
| Inflammaging markers characteristic of advanced age show similar levels with frailty and dependency A Alberro, A Iribarren-Lopez, M Sáenz-Cuesta, A Matheu, I Vergara, ... Scientific reports 11 (1), 4358, 2021 | 63 | 2021 |
| Blood miRNA expression pattern is a possible risk marker for natalizumab-associated progressive multifocal leukoencephalopathy in multiple sclerosis patients M Muñoz-Culla, H Irizar, T Castillo-Triviño, M Sáenz-Cuesta, L Sepúlveda, ... Multiple Sclerosis Journal 20 (14), 1851-1859, 2014 | 60 | 2014 |
| Transcriptomic profile reveals gender-specific molecular mechanisms driving multiple sclerosis progression H Irizar, M Munoz-Culla, L Sepulveda, M Sáenz-Cuesta, A Prada, ... PLoS One 9 (2), e90482, 2014 | 48 | 2014 |
| SncRNA (microRNA & snoRNA) opposite expression pattern found in multiple sclerosis relapse and remission is sex dependent M Muñoz-Culla, H Irizar, M Sáenz-Cuesta, T Castillo-Triviño, ... Scientific reports 6 (1), 20126, 2016 | 43 | 2016 |
| Models for studying myelination, demyelination and remyelination I Osorio-Querejeta, M Sáenz-Cuesta, M Muñoz-Culla, D Otaegui Neuromolecular medicine 19, 181-192, 2017 | 38 | 2017 |
| The first dose of fingolimod affects circulating extracellular vesicles in multiple sclerosis patients M Sáenz-Cuesta, A Alberro, M Muñoz-Culla, I Osorio-Querejeta, ... International Journal of Molecular Sciences 19 (8), 2448, 2018 | 30 | 2018 |
| Inflammaging and frailty status do not result in an increased extracellular vesicle concentration in circulation A Alberro, M Sáenz-Cuesta, M Muñoz-Culla, M Mateo-Abad, E Gonzalez, ... International Journal of Molecular Sciences 17 (7), 1168, 2016 | 29 | 2016 |
| Identification of ncRNAs as potential therapeutic targets in multiple sclerosis through differential ncRNA–mRNA network analysis H Irizar, M Muñoz-Culla, M Sáenz-Cuesta, I Osorio-Querejeta, ... BMC genomics 16, 1-15, 2015 | 22 | 2015 |
| TACI mutation in Good's Syndrome: in search of a genetic basis M Sáenz-Cuesta, N Martínez-Pomar, J de Gracia, P Echaniz, E Villegas, ... Clinical immunology (Orlando, Fla.) 145 (1), 27-30, 2012 | 22 | 2012 |
| Circulating levels of soluble apoptosis-related molecules in patients with multiple sclerosis M Moreno, M Sáenz-Cuesta, J Castilló, E Cantó, L Negrotto, ... Journal of neuroimmunology 263 (1-2), 152-154, 2013 | 18 | 2013 |
| Yerba mate (Ilex paraguariensis) inhibits lymphocyte activation in vitro M Muñoz-Culla, M Sáenz-Cuesta, MJ Guereca-Barandiaran, ML Ribeiro, ... Food & function 7 (11), 4556-4563, 2016 | 16 | 2016 |
| T cells and immune functions of plasma extracellular vesicles are differentially modulated from adults to centenarians A Alberro, I Osorio-Querejeta, L Sepúlveda, G Fernández-Eulate, ... Aging (Albany NY) 11 (22), 10723, 2019 | 14 | 2019 |
| Novel clinical applications of extracellular vesicles M Sáenz-Cuesta, M Mittelbrunn, D Otaegui Frontiers in Immunology 6, 158817, 2015 | 12 | 2015 |
| Methods for extracellular vesicles isolation in a hospital setting. Front Immunol. 2015; 6: 50 M Sáenz-Cuesta, A Arbelaiz, A Oregi, H Irizar, I Osorio-Querejeta, ... | 8 | 2015 |
| The innovative animal monitoring device for experimental autoimmune encephalomyelitis (“I AM D EAE”): A more detailed evaluation for improved results I Osorio-Querejeta, A Alberro, J Suárez, M Sáenz-Cuesta, A Oregi, ... Multiple Sclerosis and Related Disorders 63, 103836, 2022 | 1 | 2022 |
David Otaegui (orcid.org/0000-0002-6...Biodonostia Health Research Institute. Neuroimmunology GroupDirección de correo verificada de biodonostia.org
